AR098875A1 - Medios para cultivo celular - Google Patents
Medios para cultivo celularInfo
- Publication number
- AR098875A1 AR098875A1 ARP140104810A ARP140104810A AR098875A1 AR 098875 A1 AR098875 A1 AR 098875A1 AR P140104810 A ARP140104810 A AR P140104810A AR P140104810 A ARP140104810 A AR P140104810A AR 098875 A1 AR098875 A1 AR 098875A1
- Authority
- AR
- Argentina
- Prior art keywords
- medium
- phosphatidylcholine
- cholesterol
- adherent culture
- liposomes
- Prior art date
Links
- 238000004113 cell culture Methods 0.000 title 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 6
- 238000004115 adherent culture Methods 0.000 abstract 3
- 235000012000 cholesterol Nutrition 0.000 abstract 3
- 239000002502 liposome Substances 0.000 abstract 3
- 239000002609 medium Substances 0.000 abstract 3
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 abstract 3
- 239000006285 cell suspension Substances 0.000 abstract 2
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 2
- 239000000194 fatty acid Substances 0.000 abstract 2
- 229930195729 fatty acid Natural products 0.000 abstract 2
- 150000004665 fatty acids Chemical class 0.000 abstract 2
- 210000002966 serum Anatomy 0.000 abstract 2
- 238000004114 suspension culture Methods 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000010261 cell growth Effects 0.000 abstract 1
- 210000004748 cultured cell Anatomy 0.000 abstract 1
- 239000012595 freezing medium Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000012913 medium supplement Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000001814 pectin Substances 0.000 abstract 1
- 235000010987 pectin Nutrition 0.000 abstract 1
- 229920001277 pectin Polymers 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/35—Polyols, e.g. glycerin, inositol
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/36—Lipids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/46—Amines, e.g. putrescine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/50—Soluble polymers, e.g. polyethyleneglycol [PEG]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure
- C12N2500/62—DMSO
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
- C12N2533/32—Polylysine, polyornithine
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Environmental Sciences (AREA)
- Dentistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Biophysics (AREA)
- Physiology (AREA)
Abstract
La presente descripción se refiere, a un medio, por ejemplo, un reemplazo de suero, suplemento de medio, medio completo o medio de criopreservación, que comprende un tampón fisiológico básico y liposomas que comprenden colesterol, fosfatidilcolina y ácidos grasos. Se contempla que el medio provea ventajas para mejorar el crecimiento celular en cultivo en comparación con células cultivadas sin usar el reemplazo de suero descrito en la presente. Reivindicación 1: Un medio para usar con células en suspensión o en cultivo adherente, que comprende una mezcla líquida de tampón fisiológico básico y (a) liposomas que comprenden colesterol, fosfatidilcolina y ácidos grasos, en donde el liposoma está en una cantidad tal que la concentración final de colesterol en una suspensión celular o cultivo adherente va de 1 a 20 mg/L y en donde Ia concentración final de fosfatidilcolina en una suspensión celular o cultivo adherente va de 100 a 1000 mg/L; o (b) pectina; o (a) y (b).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361918833P | 2013-12-20 | 2013-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR098875A1 true AR098875A1 (es) | 2016-06-22 |
Family
ID=53399356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP140104810A AR098875A1 (es) | 2013-12-20 | 2014-12-19 | Medios para cultivo celular |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US9637721B2 (es) |
| EP (1) | EP3083978A4 (es) |
| JP (1) | JP2017500893A (es) |
| KR (1) | KR20160125352A (es) |
| CN (1) | CN106062205A (es) |
| AR (1) | AR098875A1 (es) |
| AU (1) | AU2014364368A1 (es) |
| BR (1) | BR112016014488A2 (es) |
| CA (1) | CA2934487A1 (es) |
| CL (1) | CL2016001553A1 (es) |
| EA (1) | EA201691297A1 (es) |
| IL (1) | IL246262A0 (es) |
| MX (1) | MX2016008251A (es) |
| SG (1) | SG11201604994UA (es) |
| TW (1) | TW201527534A (es) |
| WO (1) | WO2015095651A1 (es) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10918102B2 (en) | 2014-03-13 | 2021-02-16 | The General Hospital Corporation | Devices and methods to improve and assess viability of human livers |
| US11891622B2 (en) | 2014-12-30 | 2024-02-06 | Cell Cure Neurosciences Ltd. | RPE cell populations and methods of generating same |
| US11732241B2 (en) | 2015-10-15 | 2023-08-22 | Wake Forest University Health Sciences | Methods of producing in vitro liver constructs and uses thereof |
| AU2016339998B2 (en) | 2015-10-16 | 2022-04-07 | Wake Forest University Health Sciences | Multi-layer airway organoids and methods of making and using the same |
| US20180369336A1 (en) * | 2015-12-03 | 2018-12-27 | Boston Medical Center Corporation | B cell-based cancer immunotherapy |
| CN105567628B (zh) * | 2016-01-30 | 2019-07-12 | 令世鑫 | 一种全悬浮培养mdck细胞的低血清培养基 |
| CN105695407B (zh) * | 2016-03-15 | 2019-04-16 | 佰通生物技术(苏州)有限公司 | 一种对干细胞具有活化作用的微量元素组合物及其应用 |
| CN108779436A (zh) | 2016-03-18 | 2018-11-09 | 中国科学院生物物理研究所 | 一种细胞培养基和培养基补充物 |
| TW202140776A (zh) | 2016-04-26 | 2021-11-01 | 美商美國泰福生技股份有限公司 | 細胞培養基 |
| CN106119186B (zh) * | 2016-06-24 | 2019-10-08 | 肇庆大华农生物药品有限公司 | 一种用于全悬浮培养mdck细胞的无血清培养基及其制备方法 |
| CN106497872B (zh) * | 2016-12-01 | 2019-10-11 | 北京欣博睿丰医疗科技发展有限公司 | 骨骼肌干细胞无血清培养基及其制备方法和应用 |
| US12087399B2 (en) * | 2017-02-01 | 2024-09-10 | Sapphiros Ai Bio Llc | Systems and methods for customizing cell culture media for optimized cell proliferation based on genetic traits of cells |
| CA3058306A1 (en) * | 2017-03-28 | 2018-10-04 | Ajinomoto Co., Inc. | Additive for undifferentiation maintaining medium |
| CN107177542A (zh) * | 2017-05-25 | 2017-09-19 | 句容亿格纳米材料厂 | 一种促进培养基中谷氨酰胺溶解的优化方法 |
| ES2955861T3 (es) * | 2017-05-31 | 2023-12-07 | Promocell Gmbh | Medio de cultivo para células madre pluripotentes |
| US12058996B2 (en) * | 2017-06-14 | 2024-08-13 | The General Hospital Corporation | High subzero cryopreservation |
| CN107488625B (zh) * | 2017-08-31 | 2018-12-21 | 广州蕊特生物科技有限公司 | 一种胎牛血清替代物及其制备方法和应用 |
| CN109395095B (zh) * | 2017-09-18 | 2021-09-24 | 武汉原生原代生物医药科技有限公司 | 体内用生物膜及其制备方法和用途 |
| BR112020007083A2 (pt) * | 2017-10-11 | 2020-09-24 | Bast Biotechnology | composições e métodos para tratamento de fibrose |
| JP7117374B2 (ja) * | 2017-10-13 | 2022-08-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 灌流培地 |
| WO2019081609A1 (en) * | 2017-10-24 | 2019-05-02 | Fundación Instituto De Investigación Sanitaria De Santiago De Compostela (Fidis) | NANOSYSTEMS FOR CELL PROLIFERATION |
| KR102569522B1 (ko) * | 2017-11-24 | 2023-08-24 | 주식회사 차바이오랩 | 세포 동결 보존용 조성물 및 이를 이용한 세포 동결 보존 방법 |
| JP7498664B2 (ja) * | 2017-12-29 | 2024-06-12 | セル キュア ニューロサイエンシズ リミテッド | 網膜色素上皮細胞組成物 |
| US12167729B2 (en) | 2018-05-30 | 2024-12-17 | The General Hospital Corporation | Cryopreservation of tissues and organs |
| CN108853489B (zh) * | 2018-06-29 | 2019-07-02 | 陕西诺威利华生物科技有限公司 | 一种利用无血清培养基生产pedv弱毒疫苗的方法 |
| CN108815516B (zh) * | 2018-06-29 | 2019-03-15 | 陕西诺威利华生物科技有限公司 | 一种利用无血清培养基生产pedv灭活疫苗的方法 |
| CN109234223B (zh) * | 2018-11-21 | 2021-01-19 | 南京基蛋生物医药有限公司 | 低蛋白无血清细胞培养基 |
| KR102271949B1 (ko) * | 2019-04-15 | 2021-07-02 | 순천향대학교 산학협력단 | 포스파티딜콜린을 함유하는 선충 배양용 조성물 및 이를 이용한 선충의 배양방법 |
| WO2020218584A1 (ja) * | 2019-04-26 | 2020-10-29 | 味の素株式会社 | 細胞培養用組成物 |
| KR102132457B1 (ko) * | 2019-05-10 | 2020-07-09 | 주식회사 바이오솔루션 | 세포외 소포를 고농도로 배양하기 위한 세포 배양배지 및 상기 세포 배양배지를 이용한 세포외 소포 고 함유 조건화 배양액의 제조방법 |
| CN109943526B (zh) * | 2019-05-23 | 2019-09-13 | 广州赛莱拉干细胞科技股份有限公司 | 一种促间充质干细胞增殖的无血清多肽组合物 |
| US12297451B1 (en) | 2019-10-25 | 2025-05-13 | Regeneron Pharmaceuticals, Inc. | Cell culture medium |
| WO2021078935A1 (en) * | 2019-10-25 | 2021-04-29 | Fundació Centre De Regulació Genòmica | Culture media for mycoplasma |
| CN114786481A (zh) * | 2019-11-29 | 2022-07-22 | 新泽西鲁特格斯州立大学 | 用于储存血液制品的组合物、试剂盒和方法及其使用方法 |
| EP4093852A1 (en) * | 2020-01-21 | 2022-11-30 | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd | Utilization of fgf activators in culture media |
| CN111849860B (zh) * | 2020-06-01 | 2021-12-21 | 浙江大学 | 一种利用铁元素调控肠道干细胞分化的方法及应用 |
| IL298798A (en) * | 2020-06-05 | 2023-02-01 | Upside Foods Inc | Nutrient media for the production of slaughter-free meat |
| CN111534478A (zh) * | 2020-06-24 | 2020-08-14 | 肇庆大华农生物药品有限公司 | 用于培养mdck细胞系的培养基及其制备方法 |
| US20220142150A1 (en) * | 2020-11-10 | 2022-05-12 | Axogen Corporation | Packaging system for a medical product |
| CN112514892B (zh) * | 2020-12-25 | 2022-06-14 | 广州赛莱拉干细胞科技股份有限公司 | 一种外泌体冻存保护液及其制备方法 |
| CN112501113B (zh) * | 2021-02-03 | 2021-04-27 | 上海奥浦迈生物科技股份有限公司 | 一种hek293细胞组合梯度培养基及其用途 |
| CN113061584A (zh) * | 2021-05-14 | 2021-07-02 | 赵峻岭 | 一种能促进腺病毒生长的培养基添加物 |
| EP4381045A4 (en) * | 2021-08-02 | 2025-06-04 | Montana State University | Chemically defined serum replacements for cell culture |
| US11878036B2 (en) | 2022-05-25 | 2024-01-23 | Neuvian LLC | Vaginal care compositions and methods of improving vaginal health |
| WO2024024892A1 (ja) * | 2022-07-28 | 2024-02-01 | 公立大学法人山陽小野田市立山口東京理科大学 | 凍結保存用の組成物、凍結保存方法、及び凍結した細胞又は生体組織 |
| KR20240177180A (ko) * | 2023-06-19 | 2024-12-27 | (주)엑셀세라퓨틱스 | T 세포 배양용 배지 조성물 |
| WO2025098952A1 (en) | 2023-11-07 | 2025-05-15 | Evonik Operations Gmbh | Nutrient preloading of cells |
| WO2025199245A1 (en) * | 2024-03-19 | 2025-09-25 | Immunis, Inc. | Method of making and using secretome composition |
| US12421441B1 (en) | 2025-05-19 | 2025-09-23 | King Fahd University Of Petroleum And Minerals | Method for microbially enhanced oil recovery |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4721676A (en) | 1982-12-14 | 1988-01-26 | Genencor, Inc. | Novel thermophile isolate having thermostable hydrolytic activity |
| US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
| DE3827578A1 (de) | 1988-08-13 | 1990-02-15 | Siepmann Friedrich W | Verfahren und vorrichtung zur bestimmung oxidierbarer wasserinhaltsstoffe einer waessrigen probenfluessigkeit |
| US6048728A (en) | 1988-09-23 | 2000-04-11 | Chiron Corporation | Cell culture medium for enhanced cell growth, culture longevity, and product expression |
| US5834312A (en) | 1990-01-29 | 1998-11-10 | Hy-Gene, Inc. | Process and media for the growth of human epithelia |
| US5952198A (en) * | 1995-05-04 | 1999-09-14 | Bayer Corporation | Production of recombinant Factor VIII in the presence of liposome-like substances of mixed composition |
| WO1997006784A1 (en) | 1995-08-15 | 1997-02-27 | Universite Libre De Bruxelles | Liposomes preparation method and plant |
| CA2235069C (en) * | 1995-10-19 | 2010-12-14 | Advanced Reproduction Technologies, Inc. | Methods and compositions to improve germ cell and embryo survival and function |
| EP1482031B1 (en) | 1996-08-30 | 2015-10-28 | Life Technologies Corporation | Serum-free mammalian cell culture medium, and uses thereof |
| WO1998015614A1 (en) | 1996-10-10 | 1998-04-16 | Life Technologies, Inc. | Animal cell culture media comprising plant-derived nutrients |
| US6833271B2 (en) * | 1996-12-04 | 2004-12-21 | Medi-Cult A/S | Serum-free cell culture media |
| US5985538A (en) | 1997-08-01 | 1999-11-16 | Saint Barnabas Medical Center | Cryopreservation and cell culture medium comprising less than 50 mM sodium ions and greater than 100 mM choline salt |
| GB9817805D0 (en) | 1998-08-14 | 1998-10-14 | Danisco | Use of a composition |
| NZ517002A (en) | 1999-08-05 | 2004-06-25 | Mcl Llc | Multipotent adult stem cells and methods for isolation |
| US7112576B1 (en) * | 1999-12-10 | 2006-09-26 | Regents Of The University Of Minnesota | Compositions and methods for cryopreservation of peripheral blood lymphocytes |
| US7455983B2 (en) | 2000-01-11 | 2008-11-25 | Geron Corporation | Medium for growing human embryonic stem cells |
| CA2473360A1 (en) | 2002-01-25 | 2003-08-07 | Genzyme Corporation | Serum-free media for chondrocytes and methods of use thereof |
| EP1475434A1 (en) * | 2003-05-09 | 2004-11-10 | Oncoscience AG | Method for storing tumor cells |
| EP1711053A2 (en) | 2004-02-02 | 2006-10-18 | I.M.T. Interface Multigrad Technology Ltd. | Biological material and methods and solutions for preservation thereof |
| US8252591B2 (en) | 2004-05-07 | 2012-08-28 | Whitehead Institute For Biomedical Research | Hormone responsive tissue culture system and uses thereof |
| US20050287666A1 (en) | 2004-06-29 | 2005-12-29 | Invitrogen Corporation | Cell culture medium comprising transition metals or trace elements |
| EP2267116B1 (en) | 2004-07-13 | 2017-05-31 | Asterias Biotherapeutics, Inc. | Growth medium for primate embryonic stem cells |
| WO2006045064A2 (en) | 2004-10-20 | 2006-04-27 | Whitehead Institute For Biomedical Research | Cultured hematopoietic stem cells and method for expansion and analysis thereof |
| PL1807504T3 (pl) | 2004-11-02 | 2011-07-29 | Ares Trading Sa | Bezsurowicza pożywka hodowlana dla komórek ssaczych |
| EP1841856A1 (en) * | 2005-01-28 | 2007-10-10 | Canadian Blood Services | A method of cryopreserving cells and tissues by liposomal delivery of sugars to enhance post-thaw viability |
| US9101590B2 (en) | 2005-07-29 | 2015-08-11 | Yale University | Defined culture conditions of human embryonic stem cells |
| JP5205275B2 (ja) | 2005-12-21 | 2013-06-05 | セントクローネ インターナショナル エービー | 散在性ガンの治療法 |
| CN101410509B (zh) | 2006-02-23 | 2016-05-18 | 维亚赛特公司 | 用于培养可分化细胞的组合物和方法 |
| JP5080779B2 (ja) | 2006-10-25 | 2012-11-21 | テルモ株式会社 | リポソーム製剤の製造方法 |
| EP2155862A2 (en) | 2007-05-04 | 2010-02-24 | Whitehead Institute For Biomedical Research | Ex vivo expansion of human hematopoietic stem cells |
| EP2188367A4 (en) | 2007-08-10 | 2010-10-27 | Whitehead Biomedical Inst | HORMON'S TREATIVE TISSUE CULTURE SYSTEM AND USES THEREOF |
| FI20096288A0 (fi) * | 2009-12-04 | 2009-12-04 | Kristiina Rajala | Formulations and methods for culturing stem cells |
| CN103958665A (zh) * | 2011-11-11 | 2014-07-30 | 基本药品有限责任公司 | 包含血清替代物和不稳定因子的试剂盒 |
-
2014
- 2014-12-19 WO PCT/US2014/071388 patent/WO2015095651A1/en not_active Ceased
- 2014-12-19 JP JP2016560860A patent/JP2017500893A/ja active Pending
- 2014-12-19 EP EP14870754.0A patent/EP3083978A4/en not_active Withdrawn
- 2014-12-19 MX MX2016008251A patent/MX2016008251A/es unknown
- 2014-12-19 CA CA2934487A patent/CA2934487A1/en not_active Abandoned
- 2014-12-19 BR BR112016014488A patent/BR112016014488A2/pt not_active IP Right Cessation
- 2014-12-19 AR ARP140104810A patent/AR098875A1/es unknown
- 2014-12-19 EA EA201691297A patent/EA201691297A1/ru unknown
- 2014-12-19 CN CN201480075947.7A patent/CN106062205A/zh active Pending
- 2014-12-19 US US14/577,414 patent/US9637721B2/en not_active Expired - Fee Related
- 2014-12-19 KR KR1020167019241A patent/KR20160125352A/ko not_active Withdrawn
- 2014-12-19 AU AU2014364368A patent/AU2014364368A1/en not_active Abandoned
- 2014-12-19 SG SG11201604994UA patent/SG11201604994UA/en unknown
- 2014-12-19 TW TW103144675A patent/TW201527534A/zh unknown
-
2016
- 2016-06-16 CL CL2016001553A patent/CL2016001553A1/es unknown
- 2016-06-16 IL IL246262A patent/IL246262A0/en unknown
-
2017
- 2017-03-28 US US15/471,621 patent/US20170198251A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR20160125352A (ko) | 2016-10-31 |
| IL246262A0 (en) | 2016-07-31 |
| BR112016014488A2 (pt) | 2017-08-08 |
| AU2014364368A1 (en) | 2016-07-07 |
| TW201527534A (zh) | 2015-07-16 |
| MX2016008251A (es) | 2016-10-13 |
| US20150175956A1 (en) | 2015-06-25 |
| CL2016001553A1 (es) | 2017-03-17 |
| CN106062205A (zh) | 2016-10-26 |
| EP3083978A4 (en) | 2017-08-30 |
| JP2017500893A (ja) | 2017-01-12 |
| CA2934487A1 (en) | 2015-06-25 |
| EP3083978A1 (en) | 2016-10-26 |
| US9637721B2 (en) | 2017-05-02 |
| US20170198251A1 (en) | 2017-07-13 |
| WO2015095651A1 (en) | 2015-06-25 |
| EA201691297A1 (ru) | 2016-11-30 |
| SG11201604994UA (en) | 2016-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR098875A1 (es) | Medios para cultivo celular | |
| MX2019010226A (es) | Composiciones de nanoparticulas lipidicas y metodos para administracion de arnm. | |
| BR112015001620A2 (pt) | composição de meio de cultura, e método para cultivo de célula ou tecido usando-se dita composição | |
| MX2013003681A (es) | Ácidos nucleicos manipulados y métodos de uso de los mismos. | |
| MX2018010529A (es) | Composiciones y metodos para la produccion y administracion de acido ribonucleico. | |
| ES2523998T3 (es) | Método de aislamiento de citoblastos dérmicos | |
| PH12014501019A1 (en) | Kit comprising serum replacement and labile factors | |
| IN2015KN00666A (es) | ||
| AU2011327239A8 (en) | Stem cell suspension | |
| MX2015007361A (es) | Produccion mediada por la proteina portadora de acilo de los derivados de acidos grasos. | |
| EP2633036A4 (en) | DIFFERENTIATION METHOD FOR THE PRODUCTION OF GLIA CELL POPULATIONS | |
| BR112014006244A2 (pt) | microrganismos e métodos para produzir alcenos | |
| SG196784A1 (en) | Stem cell cultures | |
| DOP2014000297A (es) | Método para producir iduronato-2-sulfatasa recombinante | |
| BR112016004510A2 (pt) | composições bioativas deriváveis de concentrados de plaquetas e métodos para preparar e usar as mesmas | |
| EA201590550A1 (ru) | Композиции и способы получения гликопротеинов | |
| BR112015009229A2 (pt) | composição tendo como alvo a expressão de genes para plaquetas, célula tronco hematopoiética, uso da referida célula tronco e método in vitro ou ex vivo para gerar uma célula tronco modificada | |
| AR082943A1 (es) | Formula nutricional predigerida | |
| AR092630A1 (es) | Metodos y composiciones para prevenir la incorporacion erronea de norleucina en proteinas | |
| AR086201A1 (es) | Hongos filamentosos que tienen un fenotipo de viscosidad alterado | |
| AR096705A1 (es) | Composición que comprende ácido glutámico-n,n-diacetato (glda), agua y enzima | |
| BR112014011198A2 (pt) | dispositivos e métodos para aumento da viabiliade de bactérias em forma de bastonete | |
| WO2011097242A3 (en) | Methods of isolating and culturing mesenchymal stem cells | |
| AU340977S (en) | Carburetor float bowl | |
| MX2014004241A (es) | Composicion y metodo de fitonutrientes para efectos de programacion metabolica. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |